ARWR vs POOL · rev $829.4M vs P/E 18, rev $5.31B
Arrowhead Pharmaceuticals Inc (ARWR) versus Pool Corporation (POOL) — a side-by-side from cached financials, not a winner call.
Arrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company listed on US.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Latest reported ARWR revenue for 2025-09-30 was $829.4M. Net income was $30.1M. Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. ARWR currently screens at market cap $10.59B.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
ARWR currently screens at market cap $10.59B. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Not investment advice. Open the ARWR and POOL stock pages for the full models.
Not investment advice.